Nanalysis Scientific Corp. announced on April 8 its financial results for the fourth quarter and full year ended December 31, 2025, reporting quarterly revenue of $10.7 million and adjusted EBITDA of $1.2 million.
The company said its full-year revenue was $40.1 million, down by 12% compared to the previous year, while quarterly revenue decreased by 13% from the same period in 2024. Despite these declines, Nanalysis returned to positive adjusted EBITDA in the fourth quarter.
Chief Executive Officer Sean Krakiwsky said, “We made meaningful progress in 2025 despite a challenging operating environment.” He added that actions taken to strengthen leadership and diversify strategies have improved operational footing: “While there is work ahead, these initiatives have improved our operational footing and positioned the business for more consistent execution.” Krakiwsky also stated that as they enter 2026, their focus remains on disciplined execution and improving margins: “While revenue declined year-over-year, performance improved sequentially through 2025, with the Company returning to positive Adjusted EBITDA in the fourth quarter. This reflects the early impact of operational and strategic changes implemented throughout the year.”
Looking forward to next year’s prospects, Krakiwsky said, “We are looking forward to a stronger 2026… Our continued investment in customer and vendor relationships, combined with our differentiated technology and service offerings, positions the Company to deliver long-term value for shareholders and stakeholders alike.” He also noted efforts underway with their largest customer toward a renewed contract structure: “We are actively working with our largest customer toward a renewed and more sustainable contract structure… which we believe has the potential to materially enhance profitability and operating results over time.”
Nanalysis develops portable Nuclear Magnetic Resonance (NMR) spectrometers used globally across various industries including pharma, biotech, energy, food safety, materials science as well as academic labs. The company maintains security scanners at over eighty Canadian airports under a long-term contract valued at $160 million.
A conference call will be held on April 9 via Zoom for investors interested in further details about these results; access information is available through Nanalysis’s investor relations webpage where an archived webcast will remain accessible for at least ninety days.
